Ellipsys Vascular Access System Post Market Surveillance (PS) Study

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Renal Disease, End StageKidney Disease, End-StageAV FistulaFistulas Arteriovenous
Interventions
DEVICE

Ellipsys Vascular Access System

The Ellipsys System is indicated for the creation of a proximal radial artery to perforating vein anastomosis via a retrograde venous access approach in patients with a minimum vessel diameter of 2.0mm and less than 1.5mm of separation between the artery and vein at the fistula creation site who have chronic kidney disease requiring dialysis.

Trial Locations (12)

10305

Staten Island Hospital, Staten Island

15213

University of Pittsburg Medical Center, Pittsburgh

23236

Richmond Vascular Center, North Chesterfield

32218

Azura Vascular Care, Jacksonville, Jacksonville

32504

Coastal Vascular and Interventional, PLLC, Pensacola

60607

Rush University Medical Center, Chicago

78207

STAR Vascular Access Center, San Antonio

78216

San Antonio Kidney Disease Center, San Antonio

89128

Nephrology Kidney Disease Hypertension Center, Las Vegas

92501

Nephrology Associates Access Center, Riverside

06510

Yale University, New Haven

022601

The Vascular Care Group, Hyannis

Sponsors
All Listed Sponsors
lead

Medtronic Endovascular

INDUSTRY

NCT04484220 - Ellipsys Vascular Access System Post Market Surveillance (PS) Study | Biotech Hunter | Biotech Hunter